Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.
Janus A, Robak T, Smolewski P. Janus A, et al. Among authors: smolewski p. Cell Mol Biol Lett. 2005;10(3):479-98. Cell Mol Biol Lett. 2005. PMID: 16217558 Review.
Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T. Szmigielska-Kaplon A, et al. Among authors: smolewski p. Ann Hematol. 2002 Sep;81(9):508-13. doi: 10.1007/s00277-002-0527-7. Epub 2002 Sep 13. Ann Hematol. 2002. PMID: 12373351
Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications.
Smolewski P, Darzynkiewicz Z, Robak T. Smolewski P, et al. Leuk Lymphoma. 2003 Jul;44(7):1089-104. doi: 10.1080/1042819031000077007. Leuk Lymphoma. 2003. PMID: 12916860 Review.
The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population.
Narbutt J, Lesiak A, Zak-Prelich M, Woźniacka A, Sysa-Jedrzejowska A, Tybura M, Robak T, Smolewski P. Narbutt J, et al. Among authors: smolewski p. Cell Mol Biol Lett. 2004;9(3):497-509. Cell Mol Biol Lett. 2004. PMID: 15332126
The inhibitor of apoptosis protein family and its antagonists in acute leukemias.
Wrzesień-Kuś A, Smolewski P, Sobczak-Pluta A, Wierzbowska A, Robak T. Wrzesień-Kuś A, et al. Among authors: smolewski p. Apoptosis. 2004 Nov;9(6):705-15. doi: 10.1023/B:APPT.0000045788.61012.b2. Apoptosis. 2004. PMID: 15505413 Review.
Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Robak T, Korycka A, Kasznicki M, Wrzesien-Kus A, Smolewski P. Robak T, et al. Among authors: smolewski p. Curr Cancer Drug Targets. 2005 Sep;5(6):421-44. doi: 10.2174/1568009054863618. Curr Cancer Drug Targets. 2005. PMID: 16178817 Review.
The role of p73 in hematological malignancies.
Pluta A, Nyman U, Joseph B, Robak T, Zhivotovsky B, Smolewski P. Pluta A, et al. Among authors: smolewski p. Leukemia. 2006 May;20(5):757-66. doi: 10.1038/sj.leu.2404166. Leukemia. 2006. PMID: 16541141 Review.
Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway.
Smolewski P. Smolewski P. Anticancer Drugs. 2006 Jun;17(5):487-94. doi: 10.1097/00001813-200606000-00001. Anticancer Drugs. 2006. PMID: 16702804 Review.
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
Robak T, Smolewski P, Cebula B, Szmigielska-Kaplon A, Chojnowski K, Blonski JZ. Robak T, et al. Among authors: smolewski p. Cancer. 2006 Oct 1;107(7):1542-50. doi: 10.1002/cncr.22196. Cancer. 2006. PMID: 16948126 Clinical Trial.
Investigating mammalian target of rapamycin inhibitors for their anticancer properties.
Smolewski P. Smolewski P. Expert Opin Investig Drugs. 2006 Oct;15(10):1201-27. doi: 10.1517/13543784.15.10.1201. Expert Opin Investig Drugs. 2006. PMID: 16989597 Review.
149 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page